Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue for POD/POCD Prevention
NCT04341844Completed
- Sponsor
- Fudan University
- Start
- Jan 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of methylene blue in postoperative delirium (POD) and Post-operative cognitive dysfunction (POCD) (2 arms), sponsored by Fudan University. Primary endpoint: Incidence of postoperative delirium. Started Jan 2019; status: completed.
02
Drugs
methylene blue
03
Conditions
postoperative delirium (POD)Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT04341844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04341844.